Louis Bont

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 12 papers. Top paper: “Neonatal innate immunity in allergy development”.

Neonatal innate immunity in allergy development

Current Opinion in Pediatrics(2009)10.1097/mop.0b013e3283325e3a

N/A

2.3DataRank · unranked

50 citations

Ofer Levy, Louis Bont, Mirjam Belderbos

Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa424

N/A

0DataRank · unranked

36 citations

Anne Teirlinck, Adam Meijer, Mariëtte Hooiveld, Christiaan H. van Dorp, Rachel M Reeves +35 more

Re-emergence of respiratory syncytial virus following the COVID-19 pandemic in the United States: a modeling study

medRxiv(2021)10.1101/2021.07.19.21260817

N/A

0DataRank · unranked

4 citations

Virginia E. Pitzer, Eugene D. Shapiro, Louis Bont, Daniel M. Weinberger, Zhe Zheng

A Clinical Prediction Tool for Respiratory Syncytial Virus Lower Respiratory Tract Infection Requiring Intensive Care Unit Admission

(2021)10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3408

N/A

0DataRank · unranked

0 citations

Niek B. Achten, Tebeb Gebretsadik, Pingsheng Wu, Edward F. Mitchel, Louis Bont +2 more

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00291-2

N/A

0DataRank · unranked

443 citations

Jonne Terstappen, Ranju Baral, Azucena Bardají, Philippe Beutels, Ursula J. Buchholz +36 more

Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient Patient

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac114

N/A

0DataRank · unranked

16 citations

Emily Phung, Henriette H. M. Raeven, Gimano D. Amatngalim, Matevž Rumpret, Juliet Crabtree +21 more

Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(23)00630-8

N/A

0DataRank · unranked

101 citations

Uğurcan Koç, Teresa Bandeira, Quique Bassat, Louis Bont, Giorgi Chakhunashvili +48 more

Incorporating data from multiple endpoints in the analysis of clinical trials: example from RSV vaccines

medRxiv(2023)10.1101/2023.02.07.23285596

N/A

0DataRank · unranked

1 citations

Joukje E. Willemsen, Louis Bont, Virginia E. Pitzer, Joshua L. Warren, Daniel M. Weinberger +1 more

The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access

The Lancet Infectious Diseases(2024)10.1016/s1473-3099(24)00455-9

N/A

0DataRank · unranked

72 citations

Sarah F. Hak, Anant Bhan, Debby Bogaert, Louis Bont, Ursula J. Buchholz +26 more

Personalized Infant Risk Prediction for Severe Respiratory Syncytial Virus Lower Respiratory Tract Infection Requiring Intensive Care Unit Admission

Open Forum Infectious Diseases(2024)10.1093/ofid/ofae077

N/A

0DataRank · unranked

3 citations

Niek B. Achten, Tebeb Gebretsadik, Pingsheng Wu, Edward F. Mitchel, Gabriel J. Escobar +3 more

Assessing the strength of evidence for a causal effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a systematic review and meta-analysis

The Lancet Respiratory Medicine(2020)10.1016/s2213-2600(20)30109-0

N/A

0DataRank · unranked

110 citations

Brittney M. Snyder, Amanda J. Driscoll, Deshayne B. Fell, David A. Savitz, Daniel R. Feikin +11 more

167. Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease

Open Forum Infectious Diseases(2025)10.1093/ofid/ofae631.004

N/A

0DataRank · unranked

4 citations

Louis Bont, Paolo Manzoni, Flor M. Muñoz, Octavio Ramilo, Po‐Yen Chen +16 more